Thoracic cancers Flashcards

1
Q

Lung cancer accounts for % of all cancers?

A

14%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 5-year survival rates of lung cancer in the UK?

A

6-7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What % of lung cancers are due to smoking?

A

80-90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which types of cigarettes correlate to a higher risk of developing lung cancer?

A

Unfiltered

High-nicotine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In addition to smoking, what are the other causes/risk factors for lung cancer?

A

Passive smoking
Asbestos
Previous radiotherapy to the chest
Rarely, inhalation of radon gas, polycyclic aromatic hydrocarbons, nickel, chromate or inorganic arsenicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does recent evidence suggest in terms of the development of mixed histology commonly seen in lung cancer?

A

Lung cancers may arise in pluripotent stem cells in the bronchial epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the pathological classifications of lung cancer?

A
  1. Squamous cell carcinoma (30%)
  2. Small cell carcinoma
  3. Adenocarcinoma - acinar, papillary, bronchioalveolar, mutinous, mixed
  4. Large-cell neuroendocrine carcinoma
  5. Mixed carcinoma (e.g. adenosquamous)
  6. Giant cell carcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

For the purposes of management, how are lung cancers classified?

A

Non-small cell (NSCLC) and small cell (SCLC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the common sites of metastatic spread in lung cancer? (6)

A
  1. Regional lymph nodes
  2. Bone
  3. Liver
  4. Adrenal
  5. CNS
  6. Skin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which lung cancer classification - NSCLC or SCLC has the highest risk of metastasising?

A

SCLC (estimated 90% will have mets as presentation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which genes are involved in the development and progression of lung cancer?

A

Oncogene activation:
1. Epidermal growth factor receptor (EGFR) overexpression (70% SCLCs and 40% adenocarcinomas)
2. Point mutation of RAS or MYC
Tumour suppressor gene inactivation:
1. p53 alteration
2. BCL2 high expression in SCLC protects against apoptosis
Angiogenesis - tumour progression and metastasis:
1. Vascular endothelial growth factor (VEGF) receptor
2. Telomerase activation occurs in 100% of SCLCs and 80% of NSCLCs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A family history of lung cancer increases risk by how many times, even when smoking is taken into account?

A

2.5X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Germaine mutation of which two tumour suppressor genes can mean a genetic predisposition to the development of lung cancer?

A

p53 and Rb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How can lung cancer typically present?

A
  1. Recurrent chest infections
  2. Haemoptysis
  3. Dyspnoea
  4. Persistent cough
  5. Pleural effusion
  6. Chest pain
  7. Hoarse voice
  8. Wheeze, stridor
  9. Horner’s syndrome
  10. Weight loss
  11. Fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What investigations are/can be carried out in suspected lung cancer? (at least 5)

A
CXR
Respiratory examination
Fine needle aspiration 
Sputum cytology 
Bronchoscopy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What assessments are required in order to stage a NSCLC?

A
  1. Clinical examination (particular attention to lymph nodes, soft tissue masses)
  2. Bronchoscopy - movement of vocal chords, site of endobronchial tumour, bronchial divisions, extrinsic compression of bronchi
  3. CT chest and abdomen - size and site of primary tumour, relationship to lung fissures, mediastinum and chest wall, lymphadenopathy, metastatic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What does FDG-PET stand for?

A

Fluorodeoxyglucose positron emission tomography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Why is PET scanning recommended more than CT scanning for staging NSCLC?

A

FDG-PET scanning has a greater sensitivity and specificity than CT scanning for staging of NSCLC, and is recommended for pre-operative assessment. It is also used to exclude metastatic disease in patients being considered for radical non-surgical treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

In people with lung cancer, who is surgery most appropriate for in terms of staging?

A

In people with stages I - II lung cancer, who are fit for surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

In TNM staging of lung cancer, what does T1 refer to?

A

A tumour of 3cm or less in diameter, surrounded by lung and visceral pleura, distal to the main bronchus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What does T2 refer to?

A

Tumour 3 - 7cm diameter; or involving main bronchus 2cm or more distal to carina; or invading visceral pleura; or associated with atelectasis which extends to the hilum but does not involve the whole lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does T3 refer to?

A

Tumour >7cm; or invading chest wall, diaphragm, mediastinal pleura, or pericardium; or tumour in main bronchus <2cm distal to carina; or atelectasis of the whole lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What does T4 refer to?

A

Tumour invading mediastinum, heart, great vessels, trachea, oesophagus, vertebra, or carina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What does N0 refer to?

A

No regional node metastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What does N1 refer to?

A

Ipsilateral peribronchial or hilar node involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What does N2 refer to?

A

Ipsilateral mediastinal or subcarinal nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What does N3 refer to?

A

Contralateral mediastinal nodes; scalene; or supraclavicular nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

M0?

A

No distant metastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

M1?

A

Metastatic disease either malignant pleural effusion or distant metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What does stage I in lung cancer refer to in terms of TNM staging?

A

T 1-2 , N0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What does stage II refer to in terms of TNM staging?

A

T 1-2 N1 OR T3 N0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What does stage IIIa refer to?

A

T 1-2 N2 OR T3 N 1-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What does stage IIIb refer to?

A

T4 any N M0 OR any N3 M0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What does IV refer to?

A

Any M1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What treatment offers the best possibility of cure in NSCLC?

A

Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Which patients with NSCLC should be considered for surgery?

A

Any patient with non-metastatic NSCLC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Before the possibility of surgery, what assessments must be carried out to confirm the diagnosis of stage I or II NSCLC? (4)

A
  1. No evidence of metastases on PET scan
  2. Mediastinoscopy and lymph node biopsies
  3. Lymph nodes that appear a normal size on CT (<1cm diameter)
  4. Fitness for surgery; including co-morbidities and pulmonary function tests, spirometry etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What are the post-operative complications associated with removal of NSCLC (and possibly in many major thoracic surgeries..) (5)

A
  1. Haemorrhage
  2. Respiratory failure - opiate induced, or pneumothorax
  3. Cardiac arrhythmias, particularly AF
  4. Sepsis - chest infection, wound infection, empyema
  5. Broncho-pleural fistula
39
Q

What is the 5-year survival rate in people with stage I NSCLC?

A

60 - 80%

40
Q

Stage II 5-year survival?

A

25 - 40%

41
Q

Stage III 5-year survival?

A

10 - 30%

42
Q

Stage IV 5-year survival?

A

<5%

43
Q

In terms of radiotherapy, what does CHART stand for?

A

Continuous hyper fractionated accelerated radio therapy

44
Q

What is the standard international dose for radiotherapy?

A

60-66Gy in 30-33 fractions over 6 weeks

45
Q

What % of lung cancers are small cell? (SCLCs)

A

15-20%

46
Q

Why is staging and management of SCLCs different to NSCLCs?

A

Because SCLCs almost always demonstrate rapid growth and early dissemination and >90% have systemic disease at presentation

47
Q

What % of SCLCs are operable?

A

10%

48
Q

What is the key primary treatment for SCLCs?

A

Chemotherapy

49
Q

What are the two categories of SCLCs?

A
  1. Limited-stage disease

2. Extensive-stage disease

50
Q

What falls under the limited-stage disease category?

A

Tumour confined to one hemi-thorax and regional lymph nodes, and can be covered by tolerable radiotherapy fields

51
Q

What falls under the extensive-stage disease category?

A

Disease beyond the ‘limited-stage’ bounds.

52
Q

What are the other prognostic factors involved in staging or grouping the SCLC? (5)

A
  1. Performance status
  2. Sex (females have a better prognosis)
  3. Lactate dehydrogenase (LDH)
  4. Alkaline phosphatase
  5. Serum Na+ (hyponatraemia carries a poor prognosis)
53
Q

What does MPM stand for?

A

Malignant pleural mesothelioma

54
Q

Where does it arise from?

A

The serosal lining of the chest

55
Q

How many cases of mesothelioma are there a year in the UK?

A

Around 2200, although the incidence is expected to rise to 2500 in the next decade and fall thereafter

56
Q

What is the prognosis like for mesothelioma?

A

It is characterised by poor survival rates and is an aggressive tumour

57
Q

What is the peak age of incidence of mesothelioma?

A

60-70 years of age

58
Q

What is the male to female ratio of MPM?

A

5:1

59
Q

What % of people with MPM have an occupational history of exposure to asbestos?

A

90%

60
Q

Other than asbestos, what can more rarely cause mesothelioma? (2)

A
  • Erionite fibres (Turkey)

- thorium dioxide

61
Q

Where does the mesothelioma arise in the thorax?

A

It arises from the parietal or visceral pleura and grows diffusely within the pleural space

62
Q

What sign is commonly associated with mesothelioma?

A

Pleura effusion

63
Q

How does the tumour tend to spread?

A

It invades directly into the lung and mediastinum, and may cross the diaphragm to involve peritoneum

64
Q

What are the 3 distinct histological subtypes of malignant mesothelioma? (3)

A
  1. Epithelial (50%) - better prognosis with this pathology
  2. Sarcomatous
  3. Mixed
65
Q

What signs/symptoms are associated with malignant mesothelioma? (8)

A
  1. Chest pain
  2. Dyspnoea
  3. Systemic symptoms - fatigue, weight loss, sweating and fever
  4. Palpable chest wall mass
  5. Hoarse voice
  6. SVC obstruction
  7. Horner’s syndrome
  8. Ascites
66
Q

What is the name of the tumour in the lung associated with Horners syndrome?

A

Pancoast tumour

67
Q

What is the name of the staging system used in MPM?

A

Brigham

68
Q

What is the average survival rate in someone with untreated MPM?

A

Less than 1 year

69
Q

What are the treatment options for MPM? (4)

A
  1. Pleurodesis - Talc pleurodesis is effective in many patients in delaying the reaccumulation of pleural effusion
  2. Radiotherapy
  3. Chemotherapy
  4. Palliative care
    - surgery is very rarely an option (5%)
70
Q

Thyme tumours account for what % of all mediastinal tumours?

A

20%

71
Q

What tumours arise in the anterior mediastinum? (3)

A
  1. Thymic
  2. Lymphoma
  3. Teratoma
72
Q

In what ages does the incidence of thymomas peak?

A

Between 40-60 years of age

73
Q

Are thymomas typically fast or slow growing?

A

Slow growing

74
Q

What does thymomas typically retain the capacity to produce?

A

T-cells. The T-cells are generally of normal phenotype

75
Q

In terms of predicting prognosis and outcome, what is particularly important in a resected thymoma?

A

The presence or absence of an intact capsule and local invasion

76
Q

There are three classifications of thymoma, what are they?

A
  1. Encapsulated thymoma - benign cytology and biological behaviour (50%)
  2. Invasive thymoma - benign cytology but capable of local invasion and, rarely, distant metastases (40%)
  3. Thymic carcinoma (10%) - demonstrates cytological and biological features of cancer
77
Q

Where is metastatic spread most likely to occur with a thymoma?

A

Pleura, lung, lymph nodes and other viscera.

78
Q

What is the commonest paraneoplastic disease/effect, that occurs in approximately 15-25% if patients with thymoma?

A

Myasthenia gravis

79
Q

What investigations are carried out in people with suspected thymoma?

A
  1. Imaging by CT or MRI

2. CT-guided core biopsy preferred to FNA cytology

80
Q

What is the most common treatment of thymomas?

A

90% present with localised disease, for which surgery is best

81
Q

What is the prognosis like for people with thymoma?

A

Generally good, early stages of the disease = 10-year survival rate 70-90%. Late stage 10-year survival rate 38 - 57%

82
Q

In stage I thymoma, what is the % recurrence rate?

A

4%

83
Q

In stage IV thymoma, what is the % recurrence rate?

A

46%

84
Q

What is the pathology of 50% of lung cancers?

A

Adenocarcinoma

85
Q

What is the name of a lung cancer causing Horner’s syndrome?

A

Pancoast tumour

86
Q

If there was no spread of the pancoast tumour, what would be the treatment plan?

A

Radical treatment

87
Q

What predictive markers would help to aid treatment and prognosis in lung cancer?

A

EGFR
ALK
PDL-1

88
Q

What is the histology/characteristic of small cell lung cancer? (6)

A
  1. Cancer cells are small and oval
  2. Scanty cytoplasm
  3. Fine granular neoplasm
  4. Absent nuceoli
  5. Frequent mitosis
  6. Dense neurosecretory granules
89
Q

Which paraneoplastic syndromes are associated with small cell lung cancer? (3)

A
  1. Ectopic ACTH production
  2. Syndrome of inappropriate ADH
  3. Eaton Lambert syndrome
90
Q

Why is it important to test for oncogene presence in NSCLC?

A

As for example 15% of adenocarcinomas have EGFR and can therefore be treated really effectively with the ‘-tinib’ drugs (immunotherapy)

91
Q

Which lung cancer is most closely linked with smoking?

A

Squamous cell carcinoma

92
Q

Which lung cancer is more commonly found near the larger airways as opposed to peripherally?

A

Squamous cell carcinoma

93
Q

Which lung cancer tends to be more peripheral?

A

Adenocarcinoma